|
In June 2004, Dr. Andrew S. Kraft, a medical oncologist and nationally recognized researcher with previous appointments at National Cancer Institute (NCI) designated comprehensive cancer centers in Colorado and Alabama, accepted the position as Director of the Hollings Cancer Center. Dr. Kraft is a Professor of Medicine and Biochemistry and Molecular Biology as well as Associate Dean of Oncologic Affairs at MUSC. He also holds the distinguished William H. Folk, M.D. Chair in Experimental Oncology.
Dr. Kraft received his Bachelors of Science degree (summa cum laude) in biology from Bucknell University in 1971, and his medical degree from the University of Pennsylvania in 1975. He then completed his residency at the Mount Sinai Hospital in New York.
Dr. Kraft spent the next five years at the National Cancer Institute in Bethesda training in the Laboratory of Pathphysiology and completing his clinical fellowship in hematology/oncology. His research focus is targeted in the areas of prostate cancer, sarcomas, and novel cancer drug development, and he has been continuously funded since 1990 from the National Cancer Institute, Department of Defense and Prostate Cancer Research Foundation. He is a member of numerous societies including the American Society for Clinical Investigation, Association of American Physicians, American Association of Cancer Research and the American Society of Hematology and he has more than 100 peer-reviewed publications in leading journals such as the Journal of Biologic Chemistry, Molecular Cell Biology, Blood and Oncogene.
|
